Evidence Review · Cancer Patients · Regulatory Gaps

CAM Dangers

Most CAM-related harm to cancer patients isn't a dramatic injection death — it's quieter: a supplement silently blunting the chemotherapy that's supposed to be working.

Sources: Werneke et al., Br J Cancer 2004; Knecht, Kinder & Stockert, Front Nutr 2020; Ventola, P&T 2010.

This site's other CAM coverage documents dramatic harms: injections that kill, neck manipulations that cause strokes. But the far more common risk is quieter and easier to miss — a patient quietly taking an herbal supplement alongside chemotherapy, unaware that it can blunt the drug's effect, spike its toxicity, or trigger a dangerous interaction their oncologist never gets the chance to catch.

Why This Keeps Happening: The Regulatory Gap

In the U.S., the 1994 Dietary Supplement Health and Education Act (DSHEA) classified dietary supplements as foods rather than drugs. That single classification decision means manufacturers are not required to prove a supplement is safe or effective before selling it — the burden instead falls on the FDA to prove a product is unsafe after the fact, the reverse of how pharmaceutical approval works. Labels can claim vague effects on the body's "structure or function" (an echinacea product can say it "supports immune health") without ever being tested for interactions with the chemotherapy a buyer might also be taking.

The result: a 2007 estimate put U.S. supplement spending at $14.8 billion a year, most of it on products of unproven value, sold with no requirement to disclose interaction risks on the label. Proposed reforms — requiring pre-market safety data, standardized warning labels, and a dedicated adverse-event reporting system for supplements — have been recommended by pharmacy and medical organizations for years but have not been enacted.

What Patients Don't Tell Their Doctors

Disclosure is the first place this breaks down. Most cancer patients do not tell their oncologist or family doctor that they're using CAM — one review found this pattern across multiple studies, with disclosure higher among women and among patients with more serious diagnoses, but still far from universal. Patients seek CAM information from family, friends, and the internet far more than from their health care providers. A related survey found that while roughly 80% of providers said they consider herb-drug interaction knowledge essential, only about 15% could actually describe the specific mechanism of a given interaction — a knowledge gap on both sides of the conversation.

What a Real Hospital Found When It Looked

A cross-sectional survey at London's Royal Marsden Hospital — a specialist cancer centre — is one of the few studies to actually screen real patients for CAM-drug risk rather than just theorize about it. Of 318 cancer patients surveyed, 164 (51.6%) were taking a herbal remedy or supplement, and pharmacists flagged a concerning combination in 20 patients (12.2%). A sample of what they found:

Only 46.3% of the CAM-using patients in this study had discussed it with a healthcare professional at all.

The Mechanisms Behind the Risk

Blood thinning

Garlic, ginkgo, fish oil, ginger, and high-dose vitamin E can all affect clotting. Combined with a blood thinner, chemo drugs, or ahead of surgery, this raises bleeding risk — a concern flagged repeatedly across both the U.S. and UK literature reviewed here.

Liver enzyme interference (CYP450)

St. John's wort is the single most-studied offender: it strongly induces the liver enzyme responsible for metabolizing roughly half of all conventional medications, and has been shown to cut plasma levels of drugs ranging from cyclosporine to oral contraceptives to methadone by 20-60%. Milk thistle and goldenseal work the opposite direction, slowing drug breakdown and risking toxic buildup of drugs like paclitaxel or doxorubicin.

Antioxidant interference with treatment itself

Many chemotherapy regimens and radiation work partly by generating free radicals that damage cancer cells. High-dose antioxidant supplements (vitamin C, vitamin E, beta-carotene) could theoretically blunt that mechanism — one reason some oncology guidelines suggest suspending antioxidant supplements around treatment sessions, though the evidence here remains genuinely mixed rather than settled.

Hormonal effects

Milk thistle, licorice, soy, and black cohosh all have estrogenic activity, a specific concern for hormone-sensitive breast and gynecological cancers.

What This Means for Patients

• Tell every treating doctor and pharmacist about every supplement and herbal remedy you take — including "natural" products that seem harmless.
• Assume "natural" does not mean "no interaction risk." Several of the most dangerous interactions above involve common, widely marketed products.
• If a product claims to boost your immune system while you're on immune-targeting cancer treatment (monoclonal antibodies, immunosuppressants), that claim deserves particular scrutiny.
• Ask your cancer center's pharmacy directly — as this research shows, pharmacists are often the ones positioned to catch an interaction a rushed clinic visit might miss.